Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_assertion type Assertion NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_head.
- NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_assertion description "[To assess the expression of RET and protein products in relation to morphological types of FCDT, including follicular adenoma (FA), papillary carcinoma (PTC), follicular carcinoma (FTC) and anaplastic carcinoma (AnC), 58 non-neoplastic and neoplastic samples using pathological paraffin sections by immunohistochemistry (IHC), reverse transcriptase-polymerase chain reaction (RT-PCR) and laser capture microdissection (LCM) methods were analyzed.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_provenance.
- NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_assertion evidence source_evidence_literature NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_provenance.
- NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_assertion SIO_000772 12608895 NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_provenance.
- NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_assertion wasDerivedFrom befree-2016 NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_provenance.
- NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_assertion wasGeneratedBy ECO_0000203 NP385120.RAeQhr57LSB3yR5FGZCgMtQaCI5vX1i_8SpiA-pwrIjVM130_provenance.